FDA.reportPublic FDA data

Application 204841

Type
ANDA
Sponsor
LANNETT CO INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001SUMATRIPTANSUMATRIPTANSPRAY;NASAL5MG/SPRAYNoNo
002SUMATRIPTANSUMATRIPTANSPRAY;NASAL20MG/SPRAYNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0527-1818SumatriptanSumatriptanLannett Company, Inc.ANDACurrent
0527-1818SumatriptanSumatriptanLannett Company, Inc.ANDACurrent
0527-1818SumatriptanSumatriptanLannett Company, Inc.ANDACurrent
0527-1818SumatriptanSumatriptanLannett Company, Inc.ANDACurrent
0527-1818SumatriptanSumatriptanLannett Company, Inc.ANDACurrent
0527-1859SumatriptanSumatriptanLannett Company, Inc.ANDACurrent
0527-1859SumatriptanSumatriptanLannett Company, Inc.ANDACurrent
0527-1859SumatriptanSumatriptanLannett Company, Inc.ANDACurrent
0527-1859SumatriptanSumatriptanLannett Company, Inc.ANDACurrent
0527-1859SumatriptanSumatriptanLannett Company, Inc.ANDACurrent